SCYNEXIS, Inc. (SCYX) Discusses Transformative Asset Acquisition and Strategic Shift Toward ADPKD Therapeutics Transcript

SA Transcripts159.17K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call SCYNEXIS, Inc. (SCYX) Discusses Transformative Asset Acquisition and Strategic Shift Toward ADPKD Therapeutics March 31, 2026 8:30 AM EDT Company Participants David Angulo - CEO, President & DirectorJeremy DuffieldRossana Ferrara PontorieroIvor Macleod - Chief Financial Officer Conference Call Participants Thomas JohnsonBrian Kemp Dolliver - Brookline Capital Markets, LLC, Research DivisionVamil Divan - Guggenheim Securities, LLC, Research Division Presentation Operator Greetings, and welcome to the SCYNEXIS 2026 Corporate Update Call. [Operator Instructions] It is now my pleasure to introduce your host, Thomas Johnson of LifeSci Advisors. Thank you. You may begin.

Thomas Johnson Thank you, operator. Before we begin, let me remind you that today's call will include forward-looking statements based on current expectations, including statements concerning the financial outlook for the future, leadership's expectations on our clinical results and future financial and operational performance as well as our business strategy. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Please refer to the filings with the Securities and Exchange Commission, including our most recent annual report on Form 10-K and quarterly report on Form 10-Q, including each case under the caption Risk Factors and other documents subsequently filed with and furnished to the Securities and Exchange Commission. All forward-looking statements speak only as of today, March 31, 2026. SCYNEXIS takes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made. With that, I will turn the call over to Dr. David Angulo. David AnguloCEO, President & Director Good morning, everyone. Thank you, Thomas. I'm David Angulo, CEO of SCYNEXIS, and I'm very excited to be here today to provide you a corporate update regarding a recent completed transformative asset acquisition that has given us access